PharmaEssentia Corporation (6446.TW)

TWD 572.0

(-1.38%)

Revenue Summary of PharmaEssentia Corporation

  • PharmaEssentia Corporation's latest annual revenue in 2023 was 5.1 Billion TWD , up 77.15% from previous year.
  • PharmaEssentia Corporation's latest quarterly revenue in 2024 Q2 was 2.3 Billion TWD , up 39.5% from previous quarter.
  • PharmaEssentia Corporation reported a annual revenue of 2.88 Billion TWD in annual revenue 2022, up 339.0% from previous year.
  • PharmaEssentia Corporation reported a annual revenue of 656.5 Million TWD in annual revenue 2021, up 17.81% from previous year.
  • PharmaEssentia Corporation reported a quarterly revenue of 2.3 Billion TWD for 2024 Q2, up 39.5% from previous quarter.
  • PharmaEssentia Corporation reported a quarterly revenue of 1.26 Billion TWD for 2023 Q2, up 42.49% from previous quarter.

Annual Revenue Chart of PharmaEssentia Corporation (2023 - 2019)

Historical Annual Revenue of PharmaEssentia Corporation (2023 - 2019)

Year Revenue Revenue Growth
2023 5.1 Billion TWD 77.15%
2022 2.88 Billion TWD 339.0%
2021 656.5 Million TWD 17.81%
2020 557.25 Million TWD 82.29%
2019 305.69 Million TWD 0.0%

Peer Revenue Comparison of PharmaEssentia Corporation

Name Revenue Revenue Difference
Grape King Bio Ltd 10.63 Billion TWD 51.983%
Standard Chem & Pharm CO., LTD. 6.23 Billion TWD 18.176%
Maywufa Company Ltd. 1.3 Billion TWD -292.522%
ScinoPharm Taiwan, Ltd. 3.18 Billion TWD -60.247%
Lotus Pharmaceutical Co., Ltd. 16.95 Billion TWD 69.893%
LIWANLI Innovation Co., Ltd. 38.88 Million TWD -13029.362%
YungShin Global Holding Corporation 7.02 Billion TWD 27.353%
PhytoHealth Corporation 162.48 Million TWD -3042.13%
SCI Pharmtech, Inc. 1.2 Billion TWD -323.998%
Formosa Laboratories, Inc. 4.36 Billion TWD -17.089%
Bora Pharmaceuticals Co., LTD. 14.2 Billion TWD 64.045%